For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.

The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending.

The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened."